397 evolution "https:" "https:" "https:" "https:" "https:" "https:" "University of Minho" research jobs in France
Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
- CNRS
- Nature Careers
- Universite de Montpellier
- Institut Pasteur
- UNIVERSITE DE TECHNOLOGIE DE COMPIEGNE
- Inria, the French national research institute for the digital sciences
- Université Savoie Mont Blanc
- Université de Caen Normandie
- Grenoble INP - Institute of Engineering
- Université Gustave Eiffel
- Aix-Marseille Université
- Ecole Polytechnique
- IMT Mines Ales
- INSERM
- BRGM
- CEA-Saclay
- Ecole Normale Supérieure
- IMT Atlantique
- Centre de recherche des Cordeliers
- Ecole Normale Supérieure de Lyon
- European Synchrotron Radiation Facility
- Fondation Nationale des Sciences Politiques
- INSTITUT MAX VON LAUE - PAUL LANGEVIN
- Institut des Hautes Etudes Scientifiques
- L2CM/Université de Lorraine
- Sorbonne Université
- Télécom Paris
- University of Rouen Normandy
- University of Strasbourg
- Université côte d'azur
- Université de Bordeaux / University of Bordeaux
- Université de Lorraine
- Université de Strasbourg
- AIix-Marseille University/A*MIDEX
- Avignon Université
- CEA
- CIML2000
- CY Cergy Paris University
- Center for Immunology of Marseille-Luminy (CIML)
- Centre d'Immunologie de Marseille-Luminy
- Communauté d’universités et établissements de Toulouse
- EHESP
- ENS
- ENSICAEN
- ESPCI Paris - PSL
- Ecole Normale Superieure
- Ecole supérieure de physique et de chimie industrielles de la ville de Paris
- Ecoles Pratique des Hautes Etudes - PSL
- Fondation Hôpital Rothschild
- Fondation nationale des Sciences Politiques
- IMT - Institut Mines-Télécom
- IMT MINES ALES
- IMT Mines Albi
- IMT NORD EUROPE
- IMoST - UMR INSERM 1240
- INSERM U1112
- Inserm
- Inserm PACA Corsica
- Nantes Université
- Paris Cardiovascular Research Center, Inserm U970
- Science me Up
- Sciences Po;
- University of Tours
- Université Grenoble Alpes
- Université Paris Cité
- Université de Pau et des Pays de l'Adour
- Université de Technologie de Troyes
- École nationale des ponts et chaussées
- 58 more »
- « less
-
Field
-
Communauté d’universités et établissements de Toulouse | Toulouse, Midi Pyrenees | France | 2 months ago
Fellows conduct an independent research project hosted by an eligible Toulouse unit, with structured supervision, a Career Development Plan and advanced training (scientific & transferable skills). Key
-
at the LCMCP. The RMES team is part of the French Network on Energy Storage (https://www.energie-rs2e.com/en ) which nurtures strong scientific connections between research labs to accelerate the development
-
National Park. Where to apply Website https://emploi.cnrs.fr/Candidat/Offre/SNC9016-ROSCOS-006/Candidater.aspx Requirements Research FieldNeurosciencesEducation LevelPhD or equivalent Research
-
mapping their spin textures at the atomic scale using quantum magnetometry techniques. The work will also involve processing, analyzing, and interpreting STM/S data, contributing to instrumental development
-
in Toulouse: the LNCMI (transport measurements at very high fields), the CEMES (theory, DFT), and the LAAS (epitaxial growth and nanofabrication). Where to apply Website https://emploi.cnrs.fr/Candidat
-
of the CBI which benefits from all the technical means, equipment and technical facilities necessary for the realization of the project. Where to apply Website https://emploi.cnrs.fr/Candidat/Offre/UMR5077
-
. Postdoctoral researchers will have access to state-of-the-art imaging and cellular biology platforms, as well as a dynamic international research environment. Where to apply Website https://emploi.cnrs.fr
-
communications; Participate in project partner meetings and draft minutes; Present the project results. Where to apply Website https://utc.recruitee.com/o/chercheur-contractuel-en-bioprocedes-et-colorants-b
-
by contacting the Head of the NPP group: Dr. Michael Jentschel - email: jentsch@ill.eu (please do not send your application to this address). Where to apply Website https://jobstats.robopost.com/count
-
the development of new cancer therapies. Few UBE2N inhibitors have been described in the literature, and these are mainly covalent inhibitors, which, due to a lack of selectivity, expose patients